PACS Group, Inc. (PACS) Stock Competitors & Peer Comparison

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, TPGXL has a market cap of 21.4B. Regarding current trading prices, PACS is priced at $37.01, while TPGXL trades at $22.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas TPGXL's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to TPGXL's ROE of +0.13%. Regarding short-term risk, PACS is less volatile compared to TPGXL. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check TPGXL's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, VOYA has a market cap of 7.9B. Regarding current trading prices, PACS is priced at $37.01, while VOYA trades at $86.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas VOYA's P/E ratio is 13.10. In terms of profitability, PACS's ROE is +0.27%, compared to VOYA's ROE of +0.14%. Regarding short-term risk, PACS is less volatile compared to VOYA. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check VOYA's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, VOYA-PB has a market cap of 7.2B. Regarding current trading prices, PACS is priced at $37.01, while VOYA-PB trades at $23.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas VOYA-PB's P/E ratio is 2.81. In terms of profitability, PACS's ROE is +0.27%, compared to VOYA-PB's ROE of +0.14%. Regarding short-term risk, PACS is more volatile compared to VOYA-PB. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check VOYA-PB's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, BIPH has a market cap of 6B. Regarding current trading prices, PACS is priced at $37.01, while BIPH trades at $16.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas BIPH's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to BIPH's ROE of +0.03%. Regarding short-term risk, PACS is more volatile compared to BIPH. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check BIPH's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, BBCQW has a market cap of 1.4B. Regarding current trading prices, PACS is priced at $37.01, while BBCQW trades at $2.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas BBCQW's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to BBCQW's ROE of N/A. Regarding short-term risk, PACS is less volatile compared to BBCQW. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check BBCQW's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, MSDL has a market cap of 1.3B. Regarding current trading prices, PACS is priced at $37.01, while MSDL trades at $15.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas MSDL's P/E ratio is 15.00. In terms of profitability, PACS's ROE is +0.27%, compared to MSDL's ROE of +0.05%. Regarding short-term risk, PACS is less volatile compared to MSDL. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check MSDL's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, RILYK has a market cap of 787.6M. Regarding current trading prices, PACS is priced at $37.01, while RILYK trades at $25.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas RILYK's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to RILYK's ROE of -2.63%. Regarding short-term risk, PACS is more volatile compared to RILYK. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check RILYK's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, RILYN has a market cap of 778.3M. Regarding current trading prices, PACS is priced at $37.01, while RILYN trades at $24.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas RILYN's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to RILYN's ROE of -2.63%. Regarding short-term risk, PACS is more volatile compared to RILYN. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check RILYN's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, RILYG has a market cap of 768.6M. Regarding current trading prices, PACS is priced at $37.01, while RILYG trades at $24.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas RILYG's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to RILYG's ROE of -2.63%. Regarding short-term risk, PACS is more volatile compared to RILYG. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check RILYG's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, RILYM has a market cap of 753M. Regarding current trading prices, PACS is priced at $37.01, while RILYM trades at $25.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas RILYM's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to RILYM's ROE of -2.63%. Regarding short-term risk, PACS is more volatile compared to RILYM. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check RILYM's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, RILYT has a market cap of 668.1M. Regarding current trading prices, PACS is priced at $37.01, while RILYT trades at $21.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas RILYT's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to RILYT's ROE of -2.63%. Regarding short-term risk, PACS is more volatile compared to RILYT. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check RILYT's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, RILYO has a market cap of 573.5M. Regarding current trading prices, PACS is priced at $37.01, while RILYO trades at $25.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas RILYO's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to RILYO's ROE of -2.63%. Regarding short-term risk, PACS is more volatile compared to RILYO. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check RILYO's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, RILYP has a market cap of 523.6M. Regarding current trading prices, PACS is priced at $37.01, while RILYP trades at $16.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas RILYP's P/E ratio is 2.82. In terms of profitability, PACS's ROE is +0.27%, compared to RILYP's ROE of -2.63%. Regarding short-term risk, PACS is less volatile compared to RILYP. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check RILYP's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, RILYL has a market cap of 515.6M. Regarding current trading prices, PACS is priced at $37.01, while RILYL trades at $16.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas RILYL's P/E ratio is 2.78. In terms of profitability, PACS's ROE is +0.27%, compared to RILYL's ROE of -2.63%. Regarding short-term risk, PACS is less volatile compared to RILYL. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check RILYL's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, NWAX has a market cap of 509.2M. Regarding current trading prices, PACS is priced at $37.01, while NWAX trades at $10.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas NWAX's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to NWAX's ROE of +0.01%. Regarding short-term risk, PACS is more volatile compared to NWAX. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check NWAX's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, CRAN has a market cap of 472.3M. Regarding current trading prices, PACS is priced at $37.01, while CRAN trades at $10.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas CRAN's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to CRAN's ROE of +0.01%. Regarding short-term risk, PACS is more volatile compared to CRAN. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check CRAN's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, DBCAU has a market cap of 439.4M. Regarding current trading prices, PACS is priced at $37.01, while DBCAU trades at $10.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas DBCAU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to DBCAU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to DBCAU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check DBCAU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, CCXIU has a market cap of 433.2M. Regarding current trading prices, PACS is priced at $37.01, while CCXIU trades at $10.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas CCXIU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to CCXIU's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to CCXIU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check CCXIU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, CCXI has a market cap of 431.2M. Regarding current trading prices, PACS is priced at $37.01, while CCXI trades at $10.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas CCXI's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to CCXI's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to CCXI. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check CCXI's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, BBCQ has a market cap of 403.6M. Regarding current trading prices, PACS is priced at $37.01, while BBCQ trades at $10.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas BBCQ's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to BBCQ's ROE of N/A. Regarding short-term risk, PACS is less volatile compared to BBCQ. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check BBCQ's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, ANSCU has a market cap of 391.9M. Regarding current trading prices, PACS is priced at $37.01, while ANSCU trades at $11.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas ANSCU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to ANSCU's ROE of +0.03%. Regarding short-term risk, PACS is less volatile compared to ANSCU. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check ANSCU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, PLMKW has a market cap of 370.6M. Regarding current trading prices, PACS is priced at $37.01, while PLMKW trades at $0.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas PLMKW's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to PLMKW's ROE of +0.03%. Regarding short-term risk, PACS is less volatile compared to PLMKW. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check PLMKW's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, CXIIU has a market cap of 369M. Regarding current trading prices, PACS is priced at $37.01, while CXIIU trades at $10.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas CXIIU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to CXIIU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to CXIIU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check CXIIU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, NWAX-UN has a market cap of 365.4M. Regarding current trading prices, PACS is priced at $37.01, while NWAX-UN trades at $10.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas NWAX-UN's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to NWAX-UN's ROE of +0.01%. Regarding short-term risk, PACS is more volatile compared to NWAX-UN. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check NWAX-UN's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, CRANU has a market cap of 361.8M. Regarding current trading prices, PACS is priced at $37.01, while CRANU trades at $10.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas CRANU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to CRANU's ROE of +0.01%. Regarding short-term risk, PACS is more volatile compared to CRANU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check CRANU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, ARCI has a market cap of 351.9M. Regarding current trading prices, PACS is priced at $37.01, while ARCI trades at $9.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas ARCI's P/E ratio is -4339.13. In terms of profitability, PACS's ROE is +0.27%, compared to ARCI's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to ARCI. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check ARCI's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, SBXE has a market cap of 348.1M. Regarding current trading prices, PACS is priced at $37.01, while SBXE trades at $10.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas SBXE's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SBXE's ROE of -0.03%. Regarding short-term risk, PACS is more volatile compared to SBXE. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SBXE's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, RREV has a market cap of 333M. Regarding current trading prices, PACS is priced at $37.01, while RREV trades at $9.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas RREV's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to RREV's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to RREV. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check RREV's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, RILY has a market cap of 314.5M. Regarding current trading prices, PACS is priced at $37.01, while RILY trades at $8.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas RILY's P/E ratio is 0.58. In terms of profitability, PACS's ROE is +0.27%, compared to RILY's ROE of -2.63%. Regarding short-term risk, PACS is less volatile compared to RILY. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check RILY's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, SAC has a market cap of 314.3M. Regarding current trading prices, PACS is priced at $37.01, while SAC trades at $10.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas SAC's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SAC's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to SAC. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SAC's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, DBCA has a market cap of 308.6M. Regarding current trading prices, PACS is priced at $37.01, while DBCA trades at $9.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas DBCA's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to DBCA's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to DBCA. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check DBCA's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, KBONU has a market cap of 308.1M. Regarding current trading prices, PACS is priced at $37.01, while KBONU trades at $10.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas KBONU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to KBONU's ROE of +0.01%. Regarding short-term risk, PACS is more volatile compared to KBONU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check KBONU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, ENHA has a market cap of 307.4M. Regarding current trading prices, PACS is priced at $37.01, while ENHA trades at $2.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas ENHA's P/E ratio is -7.62. In terms of profitability, PACS's ROE is +0.27%, compared to ENHA's ROE of N/A. Regarding short-term risk, PACS is less volatile compared to ENHA. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check ENHA's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, ALOVU has a market cap of 303.2M. Regarding current trading prices, PACS is priced at $37.01, while ALOVU trades at $10.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas ALOVU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to ALOVU's ROE of +0.01%. Regarding short-term risk, PACS is less volatile compared to ALOVU. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check ALOVU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, PLMKU has a market cap of 296.9M. Regarding current trading prices, PACS is priced at $37.01, while PLMKU trades at $10.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas PLMKU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to PLMKU's ROE of +0.03%. Regarding short-term risk, PACS is more volatile compared to PLMKU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check PLMKU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, CAIIU has a market cap of 294.2M. Regarding current trading prices, PACS is priced at $37.01, while CAIIU trades at $9.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas CAIIU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to CAIIU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to CAIIU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check CAIIU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, HACQ has a market cap of 287.5M. Regarding current trading prices, PACS is priced at $37.01, while HACQ trades at $10.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas HACQ's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to HACQ's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to HACQ. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check HACQ's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, KPET has a market cap of 287.5M. Regarding current trading prices, PACS is priced at $37.01, while KPET trades at $10.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas KPET's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to KPET's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to KPET. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check KPET's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, ACAAU has a market cap of 287.3M. Regarding current trading prices, PACS is priced at $37.01, while ACAAU trades at $10.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas ACAAU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to ACAAU's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to ACAAU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check ACAAU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, XCBE has a market cap of 280.1M. Regarding current trading prices, PACS is priced at $37.01, while XCBE trades at $9.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas XCBE's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to XCBE's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to XCBE. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check XCBE's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, XSLL has a market cap of 274.3M. Regarding current trading prices, PACS is priced at $37.01, while XSLL trades at $9.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas XSLL's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to XSLL's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to XSLL. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check XSLL's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, HVII has a market cap of 271.3M. Regarding current trading prices, PACS is priced at $37.01, while HVII trades at $10.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas HVII's P/E ratio is 86.88. In terms of profitability, PACS's ROE is +0.27%, compared to HVII's ROE of +0.02%. Regarding short-term risk, PACS is more volatile compared to HVII. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check HVII's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, GIXXU has a market cap of 269M. Regarding current trading prices, PACS is priced at $37.01, while GIXXU trades at $10.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas GIXXU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to GIXXU's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to GIXXU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check GIXXU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, FACTU has a market cap of 266.9M. Regarding current trading prices, PACS is priced at $37.01, while FACTU trades at $10.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas FACTU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to FACTU's ROE of +0.03%. Regarding short-term risk, PACS is more volatile compared to FACTU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check FACTU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, SORN has a market cap of 261.3M. Regarding current trading prices, PACS is priced at $37.01, while SORN trades at $9.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas SORN's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SORN's ROE of +1.43%. Regarding short-term risk, PACS is more volatile compared to SORN. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SORN's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, MLAA has a market cap of 258.9M. Regarding current trading prices, PACS is priced at $37.01, while MLAA trades at $9.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas MLAA's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to MLAA's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to MLAA. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check MLAA's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, ALOV has a market cap of 258.9M. Regarding current trading prices, PACS is priced at $37.01, while ALOV trades at $9.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas ALOV's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to ALOV's ROE of +0.01%. Regarding short-term risk, PACS is more volatile compared to ALOV. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check ALOV's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, PLMK has a market cap of 258.4M. Regarding current trading prices, PACS is priced at $37.01, while PLMK trades at $10.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas PLMK's P/E ratio is 42.64. In terms of profitability, PACS's ROE is +0.27%, compared to PLMK's ROE of +0.03%. Regarding short-term risk, PACS is more volatile compared to PLMK. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check PLMK's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, HVIIU has a market cap of 258.3M. Regarding current trading prices, PACS is priced at $37.01, while HVIIU trades at $10.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas HVIIU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to HVIIU's ROE of +0.02%. Regarding short-term risk, PACS is more volatile compared to HVIIU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check HVIIU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, AACI has a market cap of 253.9M. Regarding current trading prices, PACS is priced at $37.01, while AACI trades at $9.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas AACI's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to AACI's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to AACI. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check AACI's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, PTOR has a market cap of 252.9M. Regarding current trading prices, PACS is priced at $37.01, while PTOR trades at $9.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas PTOR's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to PTOR's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to PTOR. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check PTOR's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, DMAAU has a market cap of 250.5M. Regarding current trading prices, PACS is priced at $37.01, while DMAAU trades at $10.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas DMAAU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to DMAAU's ROE of +0.03%. Regarding short-term risk, PACS is less volatile compared to DMAAU. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check DMAAU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, HCICU has a market cap of 250.4M. Regarding current trading prices, PACS is priced at $37.01, while HCICU trades at $10.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas HCICU's P/E ratio is 43.30. In terms of profitability, PACS's ROE is +0.27%, compared to HCICU's ROE of -0.78%. Regarding short-term risk, PACS is more volatile compared to HCICU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check HCICU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, OIMAW has a market cap of 250M. Regarding current trading prices, PACS is priced at $37.01, while OIMAW trades at $0.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas OIMAW's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to OIMAW's ROE of N/A. Regarding short-term risk, PACS is less volatile compared to OIMAW. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check OIMAW's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, CAQ has a market cap of 247.3M. Regarding current trading prices, PACS is priced at $37.01, while CAQ trades at $9.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas CAQ's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to CAQ's ROE of +9.93%. Regarding short-term risk, PACS is more volatile compared to CAQ. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check CAQ's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, SAAQ has a market cap of 247.1M. Regarding current trading prices, PACS is priced at $37.01, while SAAQ trades at $10.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas SAAQ's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SAAQ's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to SAAQ. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SAAQ's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, HCIC has a market cap of 245.7M. Regarding current trading prices, PACS is priced at $37.01, while HCIC trades at $9.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas HCIC's P/E ratio is 29.12. In terms of profitability, PACS's ROE is +0.27%, compared to HCIC's ROE of -2571.52%. Regarding short-term risk, PACS is more volatile compared to HCIC. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check HCIC's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, SBXE-UN has a market cap of 242.6M. Regarding current trading prices, PACS is priced at $37.01, while SBXE-UN trades at $10.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas SBXE-UN's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SBXE-UN's ROE of -0.03%. Regarding short-term risk, PACS is more volatile compared to SBXE-UN. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SBXE-UN's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, DRDB has a market cap of 242.4M. Regarding current trading prices, PACS is priced at $37.01, while DRDB trades at $10.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas DRDB's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to DRDB's ROE of +0.02%. Regarding short-term risk, PACS is more volatile compared to DRDB. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check DRDB's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, SSACU has a market cap of 241.4M. Regarding current trading prices, PACS is priced at $37.01, while SSACU trades at $10.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas SSACU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SSACU's ROE of -0.05%. Regarding short-term risk, PACS is more volatile compared to SSACU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SSACU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, IRHO has a market cap of 237.3M. Regarding current trading prices, PACS is priced at $37.01, while IRHO trades at $10.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas IRHO's P/E ratio is 251.75. In terms of profitability, PACS's ROE is +0.27%, compared to IRHO's ROE of +1.87%. Regarding short-term risk, PACS is more volatile compared to IRHO. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check IRHO's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, AACO has a market cap of 234.3M. Regarding current trading prices, PACS is priced at $37.01, while AACO trades at $9.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas AACO's P/E ratio is -3090.62. In terms of profitability, PACS's ROE is +0.27%, compared to AACO's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to AACO. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check AACO's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, ILLU has a market cap of 233.9M. Regarding current trading prices, PACS is priced at $37.01, while ILLU trades at $9.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas ILLU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to ILLU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to ILLU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check ILLU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, VHCP has a market cap of 230.2M. Regarding current trading prices, PACS is priced at $37.01, while VHCP trades at $10.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas VHCP's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to VHCP's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to VHCP. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check VHCP's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, LPCV has a market cap of 230M. Regarding current trading prices, PACS is priced at $37.01, while LPCV trades at $10.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas LPCV's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to LPCV's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to LPCV. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check LPCV's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, ITHA has a market cap of 230M. Regarding current trading prices, PACS is priced at $37.01, while ITHA trades at $10.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas ITHA's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to ITHA's ROE of +0.01%. Regarding short-term risk, PACS is more volatile compared to ITHA. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check ITHA's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, BLRK has a market cap of 230M. Regarding current trading prices, PACS is priced at $37.01, while BLRK trades at $10.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas BLRK's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to BLRK's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to BLRK. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check BLRK's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, ADAC has a market cap of 230M. Regarding current trading prices, PACS is priced at $37.01, while ADAC trades at $10.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas ADAC's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to ADAC's ROE of +0.01%. Regarding short-term risk, PACS is more volatile compared to ADAC. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check ADAC's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, XCBEU has a market cap of 228.8M. Regarding current trading prices, PACS is priced at $37.01, while XCBEU trades at $10.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas XCBEU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to XCBEU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to XCBEU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check XCBEU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, MEVOU has a market cap of 227.3M. Regarding current trading prices, PACS is priced at $37.01, while MEVOU trades at $10.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas MEVOU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to MEVOU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to MEVOU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check MEVOU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, DRDBU has a market cap of 222.8M. Regarding current trading prices, PACS is priced at $37.01, while DRDBU trades at $11.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas DRDBU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to DRDBU's ROE of +0.02%. Regarding short-term risk, PACS is more volatile compared to DRDBU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check DRDBU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, PTORU has a market cap of 221.8M. Regarding current trading prices, PACS is priced at $37.01, while PTORU trades at $10.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas PTORU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to PTORU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to PTORU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check PTORU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, SVAQ has a market cap of 221.6M. Regarding current trading prices, PACS is priced at $37.01, while SVAQ trades at $10.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas SVAQ's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SVAQ's ROE of +0.01%. Regarding short-term risk, PACS is more volatile compared to SVAQ. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SVAQ's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, IACQU has a market cap of 220.9M. Regarding current trading prices, PACS is priced at $37.01, while IACQU trades at $10.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas IACQU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to IACQU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to IACQU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check IACQU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, GIX has a market cap of 218.6M. Regarding current trading prices, PACS is priced at $37.01, while GIX trades at $9.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas GIX's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to GIX's ROE of +2.26%. Regarding short-term risk, PACS is more volatile compared to GIX. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check GIX's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, ACGC has a market cap of 217.9M. Regarding current trading prices, PACS is priced at $37.01, while ACGC trades at $9.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas ACGC's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to ACGC's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to ACGC. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check ACGC's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, NHIVU has a market cap of 210.2M. Regarding current trading prices, PACS is priced at $37.01, while NHIVU trades at $10.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas NHIVU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to NHIVU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to NHIVU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check NHIVU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, MUZEU has a market cap of 210.1M. Regarding current trading prices, PACS is priced at $37.01, while MUZEU trades at $10.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas MUZEU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to MUZEU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to MUZEU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check MUZEU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, TRGSU has a market cap of 209.2M. Regarding current trading prices, PACS is priced at $37.01, while TRGSU trades at $10.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas TRGSU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to TRGSU's ROE of N/A. Regarding short-term risk, PACS is less volatile compared to TRGSU. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check TRGSU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, GSRVU has a market cap of 206.3M. Regarding current trading prices, PACS is priced at $37.01, while GSRVU trades at $10.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas GSRVU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to GSRVU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to GSRVU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check GSRVU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, TRGS has a market cap of 206.1M. Regarding current trading prices, PACS is priced at $37.01, while TRGS trades at $9.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas TRGS's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to TRGS's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to TRGS. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check TRGS's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, WLII has a market cap of 205.3M. Regarding current trading prices, PACS is priced at $37.01, while WLII trades at $10.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas WLII's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to WLII's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to WLII. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check WLII's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, MUZE has a market cap of 204.9M. Regarding current trading prices, PACS is priced at $37.01, while MUZE trades at $9.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas MUZE's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to MUZE's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to MUZE. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check MUZE's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, SAC-UN has a market cap of 204.8M. Regarding current trading prices, PACS is priced at $37.01, while SAC-UN trades at $10.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas SAC-UN's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SAC-UN's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to SAC-UN. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SAC-UN's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, IDACU has a market cap of 201.4M. Regarding current trading prices, PACS is priced at $37.01, while IDACU trades at $10.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas IDACU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to IDACU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to IDACU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check IDACU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, QADR has a market cap of 198.5M. Regarding current trading prices, PACS is priced at $37.01, while QADR trades at $9.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas QADR's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to QADR's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to QADR. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check QADR's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, DYNCW has a market cap of 186.4M. Regarding current trading prices, PACS is priced at $37.01, while DYNCW trades at $0.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas DYNCW's P/E ratio is -0.16. In terms of profitability, PACS's ROE is +0.27%, compared to DYNCW's ROE of N/A. Regarding short-term risk, PACS is less volatile compared to DYNCW. This indicates potentially lower risk in terms of short-term price fluctuations for PACS.Check DYNCW's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, IPEXR has a market cap of 183.7M. Regarding current trading prices, PACS is priced at $37.01, while IPEXR trades at $0.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas IPEXR's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to IPEXR's ROE of +0.02%. Regarding short-term risk, PACS is more volatile compared to IPEXR. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check IPEXR's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, AACPU has a market cap of 181.4M. Regarding current trading prices, PACS is priced at $37.01, while AACPU trades at $10.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas AACPU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to AACPU's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to AACPU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check AACPU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, ETHM has a market cap of 178.8M. Regarding current trading prices, PACS is priced at $37.01, while ETHM trades at $10.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas ETHM's P/E ratio is -13.46. In terms of profitability, PACS's ROE is +0.27%, compared to ETHM's ROE of +0.17%. Regarding short-term risk, PACS is more volatile compared to ETHM. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check ETHM's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, BREZU has a market cap of 177.4M. Regarding current trading prices, PACS is priced at $37.01, while BREZU trades at $10.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas BREZU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to BREZU's ROE of +0.53%. Regarding short-term risk, PACS is more volatile compared to BREZU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check BREZU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, SCII has a market cap of 175.8M. Regarding current trading prices, PACS is priced at $37.01, while SCII trades at $10.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas SCII's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SCII's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to SCII. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SCII's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, PAAC has a market cap of 174.9M. Regarding current trading prices, PACS is priced at $37.01, while PAAC trades at $9.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas PAAC's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to PAAC's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to PAAC. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check PAAC's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, SUMA has a market cap of 174.5M. Regarding current trading prices, PACS is priced at $37.01, while SUMA trades at $9.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas SUMA's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SUMA's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to SUMA. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SUMA's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, IRAB has a market cap of 171.5M. Regarding current trading prices, PACS is priced at $37.01, while IRAB trades at $9.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas IRAB's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to IRAB's ROE of -0.14%. Regarding short-term risk, PACS is more volatile compared to IRAB. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check IRAB's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, PALO has a market cap of 168.8M. Regarding current trading prices, PACS is priced at $37.01, while PALO trades at $9.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas PALO's P/E ratio is -3206.45. In terms of profitability, PACS's ROE is +0.27%, compared to PALO's ROE of -0.01%. Regarding short-term risk, PACS is more volatile compared to PALO. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check PALO's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, CTAAU has a market cap of 167.7M. Regarding current trading prices, PACS is priced at $37.01, while CTAAU trades at $10.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas CTAAU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to CTAAU's ROE of +0.00%. Regarding short-term risk, PACS is more volatile compared to CTAAU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check CTAAU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, SVCCU has a market cap of 166.1M. Regarding current trading prices, PACS is priced at $37.01, while SVCCU trades at $10.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas SVCCU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SVCCU's ROE of +0.04%. Regarding short-term risk, PACS is more volatile compared to SVCCU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SVCCU's competition here

PACS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PACS stands at 5.9B. In comparison, SAGU has a market cap of 159.7M. Regarding current trading prices, PACS is priced at $37.01, while SAGU trades at $9.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PACS currently has a P/E ratio of 23.89, whereas SAGU's P/E ratio is N/A. In terms of profitability, PACS's ROE is +0.27%, compared to SAGU's ROE of N/A. Regarding short-term risk, PACS is more volatile compared to SAGU. This indicates potentially higher risk in terms of short-term price fluctuations for PACS.Check SAGU's competition here